1. Home
  2. AXR vs PLYX Comparison

AXR vs PLYX Comparison

Compare AXR & PLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$28.78

Market Cap

110.8M

Sector

Real Estate

ML Signal

HOLD

PLYX

Polaryx Therapeutics Inc. Common Stock

N/A

Current Price

$5.66

Market Cap

114.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AXR
PLYX
Founded
1961
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.8M
114.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
AXR
PLYX
Price
$28.78
$5.66
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
7.6K
3.9M
Earning Date
06-23-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
89.60
N/A
EPS
1.68
N/A
Revenue
$12,831,000.00
N/A
Revenue This Year
$12.43
N/A
Revenue Next Year
$4.48
N/A
P/E Ratio
$17.22
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.60
$2.20
52 Week High
$29.00
$8.15

Technical Indicators

Market Signals
Indicator
AXR
PLYX
Relative Strength Index (RSI) 69.19 53.24
Support Level $20.58 $2.44
Resistance Level N/A $7.39
Average True Range (ATR) 1.09 1.10
MACD 0.12 0.41
Stochastic Oscillator 90.80 61.33

Price Performance

Historical Comparison
AXR
PLYX

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About PLYX Polaryx Therapeutics Inc. Common Stock

Polaryx Therapeutics Inc is a clinical-stage biotechnology company committed to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, pediatric LSDs. Its therapeutic approach focuses on treating the underlying pathophysiology of these diseases and addressing unmet needs. The company's therapeutic pipeline includes PLX-200, PLX-300, and PLX-100, which are orally available small molecule drug candidates designed to address core pathological mechanisms common to LSDs.

Share on Social Networks: